Elisabeth Schorb on the MARTA phase 2 trial - Listen - The Lancet

The Lancet Haematology in conversation with

Elisabeth Schorb on the MARTA phase 2 trial

Listen now

Description

Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

More Episodes

See all »

Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia

Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00030-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue...

Published 03/01/24

The Lancet Haematology in conversation with

Published 03/01/24

Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies

Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies. Read the full...

Published 01/31/24